<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
INVITROGEN CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 33-0373077
(State of incorporation) (I.R.S. Employer Identification No.)
1600 FARADAY AVENUE
CARLSBAD, CALIFORNIA 92008
(Address of principal executive offices) (Zip Code)
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
Not Applicable Not Applicable
If this Form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box. / /
If this Form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), please check the following box. /X/
SECURITIES ACT REGISTRATION STATEMENT FILE NUMBER TO WHICH THIS FORM RELATES:
333-68665
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
Common Stock, $0.01 par value
(Title of class)
<PAGE>
Item 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED
The information contained under the headings "Description of Capital
Stock - Common Stock" in the Company's Registration Statement on Form S-1 (No.
333-68665) (the "Form S-1") is hereby incorporated by reference.
Item 2. EXHIBITS
The following exhibits are filed as part of this Registration
Statement:
<TABLE>
<CAPTION>
Number Description of Document
------ -----------------------
<S> <C>
1. Restated Certificate of Incorporation of the Company,
incorporated by reference to Exhibit 3.1 to the Form S-1.
2. Amended and Restated Bylaws of the Company, incorporated by
reference to Exhibit 3.2 to the Form S-1.
</TABLE>
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Company has duly caused this registration statement to be signed on
its behalf by the undersigned, thereto duly authorized.
Date: January 29, 1999
Invitrogen Corporation
By: /s/ James R. Glynn
---------------------------
James R. Glynn
Chief Financial Officer
<PAGE>
EXHIBIT INDEX
<TABLE>
<CAPTION>
Number Description of Document
------ -----------------------
<S> <C>
1. Restated Certificate of Incorporation of the Company,
incorporated by reference to Exhibit 3.1 to the Form S-1.
2. Amended and Restated Bylaws of the Company, incorporated by
reference to Exhibit 3.2 to the Form S-1.
</TABLE>
